Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-beta receptor-IgG1 fusion protein

被引:114
作者
Ettinger, R
Browning, JL
Michie, SA
vanEwijk, W
McDevitt, HO
机构
[1] STANFORD UNIV,SCH MED,DEPT MICROBIOL & IMMUNOL,STANFORD,CA 94305
[2] STANFORD UNIV,SCH MED,DEPT PATHOL,STANFORD,CA 94305
[3] BIOGEN INC,CAMBRIDGE,MA 02142
[4] DEPT VET AFFAIRS,CTR BIOL MOL,PALO ALTO,CA 94304
[5] ERASMUS UNIV ROTTERDAM,DEPT IMMUNOL,NL-3075 GE ROTTERDAM,NETHERLANDS
关键词
D O I
10.1073/pnas.93.23.13102
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Early in ontogeny, the secondary lymphoid organs become populated with numerous cells of mesodermal origin which forms both the lymphoid and stromal elements. The critical receptor/ligand interactions necessary for lymphoid organogenesis to occur are for the most part unknown, Although lymphotoxin-alpha (LT alpha) has been shown to be required for normal lymph node, Peyer's patch, and splenic development, it is unclear if soluble LT alpha 3, and/or cell-bound lymphotoxin-alpha beta (LT(YP) mediate these developmental events. Here we report that blocking LT alpha beta/lymphotoxin-beta receptor (LT beta R) interaction in vivo by generating mice which express a soluble LT beta R-Fc fusion protein driven by the human cytomegalovirus promoter results in an array of anatomic abnormalities affecting both the spleen and Peyer's patches, but not the lymph nodes. These results demonstrate that surface LT alpha beta ligand plays a critical role in normal lymphoid organ development.
引用
收藏
页码:13102 / 13107
页数:6
相关论文
共 27 条
  • [1] BANKS TA, 1995, J IMMUNOL, V155, P1685
  • [2] Developmental analysis of the cytomegalovirus enhancer in transgenic animals
    Baskar, JF
    Smith, PP
    Ciment, GS
    Hoffmann, S
    Tucker, C
    Tenney, DJ
    ColbergPoley, AM
    Nelson, JA
    Ghazal, P
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (05) : 3215 - 3226
  • [3] The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice
    Baskar, JF
    Smith, PP
    Nilaver, G
    Jupp, RA
    Hoffmann, S
    Peffer, NJ
    Tenney, DJ
    ColbergPoley, AM
    Ghazal, P
    Nelson, JA
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (05) : 3207 - 3214
  • [4] Preparation and characterization of soluble recombinant heterotrimeric complexes of human lymphotoxins alpha and beta
    Browning, JL
    Miatkowski, K
    Griffiths, DA
    Bourdon, PR
    Hession, C
    Ambrose, CM
    Meier, W
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (15) : 8618 - 8626
  • [5] LYMPHOTOXIN-BETA, A NOVEL MEMBER OF THE TNF FAMILY THAT FORMS A HETEROMERIC COMPLEX WITH LYMPHOTOXIN ON THE CELL-SURFACE
    BROWNING, JL
    NGAMEK, A
    LAWTON, P
    DEMARINIS, J
    TIZARD, R
    CHOW, EPC
    HESSION, C
    OBRINEGRECO, B
    FOLEY, SF
    WARE, CF
    [J]. CELL, 1993, 72 (06) : 847 - 856
  • [6] THE BINDING-AFFINITY OF HUMAN-IGG FOR ITS HIGH-AFFINITY FC RECEPTOR IS DETERMINED BY MULTIPLE AMINO-ACIDS IN THE CH2 DOMAIN AND IS MODULATED BY THE HINGE REGION
    CANFIELD, SM
    MORRISON, SL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (06) : 1483 - 1491
  • [7] A Lymphotoxin-β-Specific Receptor
    Crowe, Paul D.
    VanArsdale, Todd L.
    Walter, Barbara N.
    Ware, Carl F.
    Hession, Catherine
    Ehrenfels, Barbara
    Browning, Jeffrey L.
    Din, Wenie S.
    Goodwin, Raymond G.
    Smith, Craig A.
    [J]. JOURNAL OF IMMUNOLOGY, 2014, 192 (05) : 2015 - 2018
  • [8] Abnormal Development of Peripheral Lymphoid Organs in Mice Deficient in Lymphotoxin
    De Togni, Pietro
    Goellner, Josphe
    Ruddle, Nancy H.
    Streeter, Philip R.
    Fick, Andrea
    Mariathasan, Sanjeev
    Smith, Stacy C.
    Carison, Rebecca
    Shonnick, Laurie P.
    strauss-Schoenberger, Jena
    Russell, John H.
    Karr, Robert
    Chaplin, David D.
    [J]. JOURNAL OF IMMUNOLOGY, 2014, 192 (05) : 2010 - 2014
  • [9] DECREASED SENSITIVITY TO TUMOR-NECROSIS-FACTOR BUT NORMAL T-CELL DEVELOPMENT IN TNF RECEPTOR-2-DEFICIENT MICE
    ERICKSON, SL
    DESAUVAGE, FJ
    KIKLY, K
    CARVERMOORE, K
    PITTSMEEK, S
    GILLETT, N
    SHEEHAN, KCF
    SCHREIBER, RD
    GOEDDEL, DV
    MOORE, MW
    [J]. NATURE, 1994, 372 (6506) : 560 - 563
  • [10] FORCE WR, 1995, J IMMUNOL, V155, P5280